AHPA
Organogenesis Holdings Inc.
A regenerative medicine company that grows living skin and tissue products to help wounds heal. Its best-known product, Apligraf, is a living skin substitute used to treat diabetic foot ulcers and venous leg ulcers, while its PuraPly and Affinity lines provide antimicrobial and amniotic membrane dressings for surgeons and wound-care clinics. Founded in 1985 in Massachusetts, the company's name reflects its founding mission of growing organs and tissues in the lab rather than just making bandages.
SPACUnderlying: AHPACINS: G0726L109HealthcareUS1 holder
Class A Ordinary Shares — Merged into Organogenesis Holdings Inc. (ORGO) in December 2018
Total Value
$20.59M
Total Shares
1.99M
Net Share Change
+100.3K
Activity
1 buying
Investor
Value
Shares
Weight
Change
